Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Approval for Clobetasol Propionate Spray, 0.05%. The company has submitted its press release.
The above information is a part of company’s filings submitted to BSE.